Five Prime Therapeutics, Inc. Announces Closing of Initial Public Offering
Published: Sep 24, 2013
SOUTH SAN FRANCISCO, Calif., Sept. 23, 2013 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) (Five Prime) announced today the closing of its initial public offering of 4,800,000 shares, resulting in aggregate gross proceeds of $62.4 million, before underwriting discounts, commissions and expenses. All of such shares were sold by Five Prime at an initial offering price of $13.00 per share.
Help employers find you! Check out all the jobs and post your resume.